Biohaven Ltd. (BHVN) Insider Trading
Directors, officers and holders of more than 10% of BHVN report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 77 transactions on file: 10 with code P, 0 with code S and 40 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Gentile Kimberly | SVP, Clinical Operations | A Award | 1,000 | Not measured | Not measured |
| Apr 28, 2026 | CHILDS JOHN W | Director | A Award | 68,693 | Not measured | Not measured |
| Apr 28, 2026 | Heffernan Michael Thomas | Director | A Award | 68,693 | Not measured | Not measured |
| Apr 28, 2026 | Bailey Gregory | Director | A Award | 68,693 | Not measured | Not measured |
| Apr 28, 2026 | HUGIN ROBERT J | Director | A Award | 68,693 | Not measured | Not measured |
| Apr 28, 2026 | GREGORY JULIA P | Director | A Award | 68,693 | Not measured | Not measured |
| Apr 28, 2026 | Antonijevic Irina | Director | A Award | 68,693 | Not measured | Not measured |
| Apr 28, 2026 | Mehta Kishan | Director | A Award | 68,693 | Not measured | Not measured |
| Mar 17, 2026 | Mehta Kishan | Director | G Gift | 17,342 | Not measured | Not measured |
| Mar 17, 2026 | Mehta Kishan | Director | G Gift | 17,342 | Not measured | Not measured |
| Feb 27, 2026 | Coric Vlad | Chief Executive Officer | A Award | 550,000 | Not measured | Not measured |
| Feb 27, 2026 | Buten Matthew | Chief Financial Officer | A Award | 175,000 | Not measured | Not measured |
| Feb 27, 2026 | Gentile Kimberly | SVP, Clinical Operations | A Award | 175,000 | Not measured | Not measured |
| Feb 27, 2026 | Clark George C. | VP, Chief Accounting Officer | A Award | 50,000 | Not measured | Not measured |
| Feb 27, 2026 | Car Bruce | Chief Scientific Officer | A Award | 175,000 | Not measured | Not measured |
| Jan 5, 2026 | Buten Matthew | Chief Financial Officer | M Exercise | 4,250 | Not measured | Not measured |
| Jan 5, 2026 | Clark George C. | VP, Chief Accounting Officer | F Tax Payment | 1,117 | $9.93 | $11,092 |
| Jan 5, 2026 | Buten Matthew | Chief Financial Officer | M Exercise | 4,250 | Not measured | Not measured |
| Jan 5, 2026 | Buten Matthew | Chief Financial Officer | F Tax Payment | 2,594 | $9.93 | $25,758 |
| Jan 5, 2026 | Car Bruce | Chief Scientific Officer | M Exercise | 4,750 | Not measured | Not measured |
| Jan 5, 2026 | Car Bruce | Chief Scientific Officer | F Tax Payment | 2,381 | $9.93 | $23,643 |
| Jan 5, 2026 | Coric Vlad | Chief Executive Officer | M Exercise | 14,250 | Not measured | Not measured |
| Jan 5, 2026 | Coric Vlad | Chief Executive Officer | F Tax Payment | 7,430 | $9.93 | $73,780 |
| Jan 5, 2026 | Gentile Kimberly | SVP, Clinical Operations | M Exercise | 3,750 | Not measured | Not measured |
| Jan 5, 2026 | Gentile Kimberly | SVP, Clinical Operations | F Tax Payment | 1,956 | $9.93 | $19,423 |
| Jan 5, 2026 | Clark George C. | VP, Chief Accounting Officer | M Exercise | 2,500 | Not measured | Not measured |
| Jan 5, 2026 | Gentile Kimberly | SVP, Clinical Operations | M Exercise | 3,750 | Not measured | Not measured |
| Jan 5, 2026 | Coric Vlad | Chief Executive Officer | M Exercise | 14,250 | Not measured | Not measured |
| Jan 5, 2026 | Car Bruce | Chief Scientific Officer | M Exercise | 4,750 | Not measured | Not measured |
| Jan 5, 2026 | Clark George C. | VP, Chief Accounting Officer | M Exercise | 2,500 | Not measured | Not measured |
| Nov 17, 2025 | Clark George C. | VP, Chief Accounting Officer | P Purchase | 17,000 | $8.52 | $144,770 |
| Nov 13, 2025 | Coric Vlad | Chief Executive Officer | P Purchase | 333,333 | $7.50 | $2,499,998 |
| Nov 13, 2025 | Coric Vlad | Chief Executive Officer | P Purchase | 333,333 | $7.50 | $2,499,998 |
| Nov 13, 2025 | CHILDS JOHN W | Director | P Purchase | 3,333,333 | $7.50 | $24,999,998 |
| Nov 13, 2025 | Bailey Gregory | Director | P Purchase | 400,000 | $7.50 | $3,000,000 |
| May 5, 2025 | CHILDS JOHN W | Director | A Award | 31,716 | Not measured | Not measured |
| May 5, 2025 | Antonijevic Irina | Director | A Award | 31,716 | Not measured | Not measured |
| May 5, 2025 | Heffernan Michael Thomas | Director | A Award | 31,716 | Not measured | Not measured |
| May 5, 2025 | Bailey Gregory | Director | A Award | 31,716 | Not measured | Not measured |
| May 5, 2025 | Mehta Kishan | Director | A Award | 31,716 | Not measured | Not measured |
| May 5, 2025 | GREGORY JULIA P | Director | A Award | 31,716 | Not measured | Not measured |
| May 5, 2025 | HUGIN ROBERT J | Director | A Award | 31,716 | Not measured | Not measured |
| Mar 4, 2025 | CHILDS JOHN W | Director | P Purchase | 28,400 | $30.43 | $864,115 |
| Mar 4, 2025 | CHILDS JOHN W | Director | P Purchase | 25,000 | $30.39 | $759,648 |
| Mar 4, 2025 | CHILDS JOHN W | Director | P Purchase | 900 | $30.73 | $27,653 |
| Mar 4, 2025 | CHILDS JOHN W | Director | P Purchase | 3,400 | $30.73 | $104,469 |
| Mar 4, 2025 | CHILDS JOHN W | Director | P Purchase | 3,400 | $30.73 | $104,469 |
| Jan 5, 2025 | Clark George C. | VP, Chief Accounting Officer | M Exercise | 2,500 | Not measured | Not measured |
| Jan 5, 2025 | Gentile Kimberly | SVP, Clinical Operations | F Tax Payment | 1,956 | $38.64 | $75,580 |
| Jan 5, 2025 | Gentile Kimberly | SVP, Clinical Operations | M Exercise | 3,750 | Not measured | Not measured |
The full Form 4 history is on the BHVN company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.